Phase II, open, one-site, pilot Clinical trial for assessing the pharmacokinetic characteristics, safety and tolerability after conversion of the immuno-suppressive regimen with Advagraf to Envarsus in patients with stable pulmonary transplant.
Phase of Trial: Phase II
Latest Information Update: 27 Sep 2017
At a glance
- Drugs Tacrolimus (Primary)
- Indications Lung transplant rejection
- Focus Pharmacokinetics
- Acronyms TX PULMONARY
- 27 Sep 2017 Results presented at the 18th Congress of the European Society for Organ Transplantation
- 13 May 2017 Status changed from recruiting to completed.
- 28 Apr 2016 New trial record